Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

Introduction Percutaneous coronary intervention (PCI)-related myocardial infarction (type 4a MI) and major periprocedural myocardial injury have been demonstrated leading to poor prognosis of patients with coronary heart disease (CHD) undergoing elective PCI and still remain high occurrence even aft...

Full description

Bibliographic Details
Main Authors: Yang Chen, Suhua Li, Lianxiong Yuan, Zhenyu Xiong, Jinlai Liu, Xiaoxian Qian, Longgen Xiong, Leile Tang, Zhuoshan Huang, Xiaodong Zhuang, Shaozhao Zhang, Yiquan Huang, Aiwen Lin, Odong Christopher, Bingyuan Wu, Yesheng Ling, Qiang Jie, Xinxue Liao
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/7/e072541.full

Internet

https://bmjopen.bmj.com/content/13/7/e072541.full

Similar Items